Materialise NV reported an overall revenue increase of 4.2% to €266,765k in 2024, with a notable 14.8% rise in the Medical segment. However, net profit improved from a loss of €539k in Q4 2023 to a profit of €2,907k in Q4 2024, with significant expenses rising, particularly in R&D (up 19.6%).